Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) has scheduled its second quarter 2025 financial results announcement for July 31, 2025, before market opening. The company will host a conference call at 8:00 AM ET on the same day to discuss the quarterly results and corporate activities.
Investors can participate by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 9430387. The call will be simultaneously webcast on www.vandapharma.com. A replay will be available from 11:00 AM ET until August 7, 2025, at 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 31 luglio 2025, prima dell'apertura del mercato. La società terrà una conference call alle 8:00 AM ET dello stesso giorno per discutere i risultati trimestrali e le attività aziendali.
Gli investitori potranno partecipare chiamando il numero 1-800-715-9871 (nazionale) o 1-646-307-1963 (internazionale) utilizzando il codice di accesso 9430387. La chiamata sarà trasmessa in diretta anche sul sito www.vandapharma.com. Una registrazione sarà disponibile in replica dalle 11:00 AM ET fino al 7 agosto 2025, alle 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 31 de julio de 2025, antes de la apertura del mercado. La compañía realizará una llamada conferencia a las 8:00 AM ET ese mismo día para discutir los resultados trimestrales y las actividades corporativas.
Los inversores pueden participar llamando al 1-800-715-9871 (nacional) o al 1-646-307-1963 (internacional) usando el código de acceso 9430387. La llamada será transmitida simultáneamente en www.vandapharma.com. Una repetición estará disponible desde las 11:00 AM ET hasta el 7 de agosto de 2025 a las 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA)는 2025년 2분기 재무 결과 발표를 2025년 7월 31일 시장 개장 전으로 예정했습니다. 회사는 같은 날 오전 8시 ET에 분기 실적과 기업 활동에 대해 논의하는 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 국내 전화번호 1-800-715-9871 또는 국제 전화번호 1-646-307-1963에 접속 코드 9430387를 사용해 참여할 수 있습니다. 콜은 www.vandapharma.com에서 실시간 웹캐스트로도 제공됩니다. 녹음은 2025년 8월 7일 오후 11시 59분 ET까지 오전 11시 ET부터 이용 가능합니다.
Vanda Pharmaceuticals (Nasdaq : VNDA) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 31 juillet 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique à 8h00 ET le même jour pour discuter des résultats trimestriels et des activités de l'entreprise.
Les investisseurs peuvent participer en appelant le 1-800-715-9871 (numéro national) ou le 1-646-307-1963 (numéro international) avec le code d'accès 9430387. La conférence sera également diffusée en direct sur www.vandapharma.com. Un replay sera disponible de 11h00 ET jusqu'au 7 août 2025 à 23h59 ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 31. Juli 2025, vor Börsenöffnung, geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die Quartalsergebnisse und Unternehmensaktivitäten zu besprechen.
Investoren können teilnehmen, indem sie die Nummer 1-800-715-9871 (inländisch) oder 1-646-307-1963 (international) mit dem Zugangscode 9430387 wählen. Der Anruf wird gleichzeitig auf www.vandapharma.com live übertragen. Eine Aufzeichnung ist von 11:00 Uhr ET bis zum 7. August 2025, 23:59 Uhr ET, verfügbar.
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 8:00 AM ET on Thursday, July 31, 2025, during which management will discuss the second quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9430387.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, July 31, 2025, beginning at 11:00 AM ET and will be accessible until Thursday, August 7, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9430387.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2025-financial-results-on-july-31-2025-302512437.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda Pharmaceuticals (VNDA) release Q2 2025 earnings?
How can investors join Vanda Pharmaceuticals' Q2 2025 earnings call?
What time is Vanda Pharmaceuticals' Q2 2025 earnings call?
How long will Vanda Pharmaceuticals' Q2 2025 earnings call replay be available?
